subscribeSubscribe
price-trendAsk Us
Cortexyme Announces Preclinical Data Showing Benefits of Atuzaginstat

Cortexyme Announces Preclinical Data Showing Benefits of Atuzaginstat
BUSINESSWIRE
09 Mar 2022
Share Share
Cortexyme to focus on 2nd Alzheimer`s bet after clinical hold

Cortexyme to focus on 2nd Alzheimer`s bet after clinical hold
K. LaHucik FIERCEBIOTECH
27 Jan 2022
Share Share
Cortexyme picks a lower dose for nebulous Alzheimer`s drug

Cortexyme picks a lower dose for nebulous Alzheimer`s drug
N. Pagliarulo BIOPHARMADIVE
13 Nov 2021
Share Share
Cortexyme will forge ahead with failed Alzheimer`s drug

Cortexyme will forge ahead with failed Alzheimer`s drug
D. Garde STATNEWS
27 Oct 2021
Share Share
Cortexyme Expands Pipeline with Initiation of Phase 1 Trial of COR588

Cortexyme Expands Pipeline with Initiation of Phase 1 Trial of COR588
BUSINESSWIRE
08 Sep 2021
Share Share